The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft National Vigilance Strategy for Medical Products 2025 for your review and feedback.
We kindly request you to provide your comments, suggestions, or recommendations directly within the documents where “commentary access” has been granted. Please refer to the link (Draft National vigilance strategy for medical products 2025) to access the draft strategy. We would appreciate receiving your inputs by 24 January 2026.
Thank you for your valuable input and cooperation